Opin vísindi

Fletta eftir höfundi "Tryggvadottir, Laufey"

Fletta eftir höfundi "Tryggvadottir, Laufey"

Röðun: Raða: Niðurstöður:

  • Icon
    Áttavitinn – rannsókn á reynslu einstaklinga af greiningu og meðferð krabbameina á Íslandi árin 2015-2019 
    Torfadóttir, Jóhanna E.; Einarsdóttir, Sigrún Eva; Helgason, Asgeir R.; Þórisdottir, Birna; Gudmundsdottir, Rebekka Bjorg; Unnarsdottir, Anna Bara; Tryggvadottir, Laufey; Birgisson, Helgi; Thorvaldsdottir, Gudfinna Halla (2022-10-01)
    Spáð er mikilli fjölgun krabbameinstilfella á Íslandi næstu áratugi. Mikilvægt er að fá aukna innsýn í reynslu þeirra sem greinast með krabbamein með það að markmiði að bæta lífsgæði þeirra og horfur.
  • Icon
    Breast cancer survival in Nordic BRCA2 mutation carriers—unconventional association with oestrogen receptor status 
    Olafsdottir, Elinborg J.; Borg, Ake; Jensen, Maj Britt; Gerdes, Anne Marie; Johansson, Anna L.V.; Barkardottir, Rosa B.; Johannsson, Oskar T.; Ejlertsen, Bent; Sønderstrup, Ida Marie Heeholm; Hovig, Eivind; Lænkholm, Anne Vibeke; Hansen, Thomas van Overeem; Olafsdottir, Gudridur H.; Rossing, Maria; Jonasson, Jon G.; Sigurdsson, Stefan; Loman, Niklas; Nilsson, Martin P.; Narod, Steven A.; Tryggvadottir, Laufey (2020-11-24)
    Background: The natural history of breast cancer among BRCA2 carriers has not been clearly established. In a previous study from Iceland, positive ER status was a negative prognostic factor. We sought to identify factors that predicted survival after ...
  • Icon
    Estrogen receptor-positive breast cancer and adverse outcome in BRCA2 mutation carriers and young non-carrier patients 
    Vidarsdottir, Linda; Olafsdottir, Elinborg J.; Barkardóttir, Rósa Björk; Bjarnadóttir, Ólöf Kristjana; Jónasson, Jón Gunnlaugur; Sigurdsson, Stefan; Tryggvadottir, Laufey (2023-11-30)
    Estrogen receptor-positive (ER+) breast cancer generally confers a more favorable prognosis than ER-negative cancer, however, a different picture is emerging for BRCA2 mutation carriers and young patients. We used nationwide data from population-based ...
  • Icon
    Genetics and epidemiology of mutational barcode-defined clonal hematopoiesis 
    Stacey, Simon N.; Zink, Florian; Halldórsson, Gísli Hreinn; Stefánsdóttir, Lilja; Guðjónsson, Sigurjón Axel; Einarsson, Gudmundur; Hjörleifsson, Grimur; Eiríksdóttir, Þjóðbjörg; Helgadottir, Anna; Björnsdottir, Gyda; Thorgeirsson, Thorgeir E.; Ólafsdóttir, Þórunn Ásta; Jónsdóttir, Ingileif; Gretarsdottir, Solveig; Tragante, Vinicius; Magnússon, Magnús Karl; Jonsson, Hakon; Gudmundsson, Julius; Olafsson, Sigurgeir; Holm, Hilma; Gudbjartsson, Daniel F.; Sulem, Patrick; Helgason, Agnar Sturla; Þorsteinsdóttir, Unnur; Tryggvadottir, Laufey; Rafnar, Thorunn; Melsted, Páll; Úlfarsson, Magnús Örn; Viðarsson, Brynjar; Thorleifsson, Gudmar; Stefánsson, Kári (2023-12)
    Clonal hematopoiesis (CH) arises when a substantial proportion of mature blood cells is derived from a single hematopoietic stem cell lineage. Using whole-genome sequencing of 45,510 Icelandic and 130,709 UK Biobank participants combined with a mutational ...
  • Icon
    In situ breast cancer incidence patterns in Iceland and differences in ductal carcinoma in situ treatment compared to Sweden 
    Agustsson, Arnar S.; Birgisson, Helgi; Agnarsson, Bjarni A.; Jonsson, Thorvaldur; Stefansdottir, Hrefna; Wärnberg, Fredrik; Lambe, Mats; Tryggvadottir, Laufey; Sverrisdottir, Asgerdur (2020-12-01)
    The purpose was to review the incidence of in situ carcinoma in Iceland after initiating population-based mammography screening in 1987 and to compare management of ductal carcinoma in situ (DCIS) between Iceland and the Uppsala–Örebro region (UÖR) in ...